GlobeNewswire 2019-10-30 David Eatwell to Retire as Chief Financial Officer of Genmab

GlobeNewswire 2019-10-18 CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Lenalidomide a...

GlobeNewswire 2019-10-15 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2019

GlobeNewswire 2019-09-26 Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Bortezomib, Thalid...

GlobeNewswire 2019-09-13 Genmab Announces Positive Topline Results in Phase III Study of Daratumumab in Combination with Carf...

GlobeNewswire 2019-09-13 Detailed Results from the Phase III ASCLEPIOS I & II Studies of Ofatumumab in Patients with Relapsin...

GlobeNewswire 2019-09-09 Genmab and Tempus Enter into Strategic Collaboration Agreement

GlobeNewswire 2019-08-30 Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Scle...

GlobeNewswire 2019-08-22 Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan

GlobeNewswire 2019-08-14 Genmab Announces Financial Results for the First Half of 2019 and Updates 2019 Financial Guidance

GlobeNewswire 2019-07-23 Genmab Announces the Closing of Over-Allotment Option in Initial Public Offering of American Deposit...

GlobeNewswire 2019-07-22 Genmab Announces the Completion of its Initial Public Offering of American Depositary Shares (ADSs) ...

GlobeNewswire 2019-07-19 Major Shareholder Announcement

GlobeNewswire 2019-07-19 Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering

GlobeNewswire 2019-07-18 Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States

GlobeNewswire 2019-07-16 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2019

GlobeNewswire 2019-07-12 Genmab Announces Submission of Biologics License Application to U.S. FDA for Subcutaneous Formulatio...

GlobeNewswire 2019-07-09 Genmab Commences Public Offering of American Depositary Shares (ADSs) in the United States

GlobeNewswire 2019-07-08 Genmab Announces Positive Topline Results in the Phase II GRIFFIN Study of Transplant Eligible, Newl...

GlobeNewswire 2019-06-27 Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Lenalidomide and D...

GlobeNewswire 2019-06-25 Major Shareholder Announcement

GlobeNewswire 2019-06-19 Major Shareholder Announcement

GlobeNewswire 2019-06-11 Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38

GlobeNewswire 2019-05-30 U.S. FDA Grants Priority Review for Daratumumab in Combination with Bortezomib, Thalidomide and Dexa...